AI Article Synopsis
- Multisystem inflammatory syndrome in children (MIS-C) is a serious condition linked to COVID-19 that causes severe inflammation in multiple systems of the body.
- A 13-year-old boy in Japan with MIS-C experienced a cardiac arrest and was treated with immunosuppressive therapy and mechanical circulatory support (MCS) devices, leading to his recovery.
- This case highlights the need for prompt and effective treatment with immunosuppressive therapy and MCS devices for patients with MIS-C.
Article Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a novel hyperinflammatory syndrome that is associated with severe acute respiratory syndrome coronavirus 2 infections. Reports describing the mechanical circulatory support (MCS) and myocardial biopsy for fulminant myocarditis due to MIS-C are limited.A 13-year-old male patient with MIS-C underwent treatment, including immunosuppressive therapy and MCS devices, and managed to recover from pulseless electrical activity cardiac arrest.This is the first patient in Japan with MIS-C who required MCS devices in Japan. Appropriate and immediate treatment with immunosuppressive therapy and MCS devices is important.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1536/ihj.23-116 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!